Lovastatin Useful in Fighting Malaria

Saturday, August 10th, 2013

Lovastatin, a medication generally indicated for lowering cholesterol levels, has recently been found by a study to be a positive addition to traditional antimalarial treatments. The medicine helps by reducing neuro-inflammation and protecting the brain against cognitive impairment in mouse tests of cerebral malaria. There is significant difference between mouse models of the disease and […]

Lovastatin Patent Verdict- Merck gets Substantial Damages

Friday, August 9th, 2013

The Federal Court recently ruled on the Lovastatin patent case and held that Merck and Co., Inc. and Merck Canada Inc. are entitled to more than $119 million in damages from Apotex, Inc. Apotex was found to have infringed Canadian patent number 1,161,380 for the anti-cholesterol drug lovastatin (brand name Mevacor). Apotex argued the case […]

Lovastatin Safety Confirmed in Large-scale Study

Tuesday, July 30th, 2013

A large-scale analysis of trials that included a quarter of a million people has shown that lovastatin and other statins are well-tolerated. Statins like lovastatin have been generally associated with a greater risk of liver problems and diabetes when compared to placebo, although there was no difference in risks of other conditions like cancer or […]

Lovastatin and Other Statins May Turn More Toxic With Certain Antibiotics

Friday, July 12th, 2013

A recent study indicated that the combination of antibiotics like clarithromycin with statins like lovastatin may increase the risk of statin toxicity. This study, which was a popular-based cohort, aimed at measuring the statin toxicity frequency after combining statins with clarithromycin and erythromycin. The study was done in Ontario during a period from 2003 to […]